A registry to track management of new patients who are being treated medically for a number of vascular diseases has been launched by the Society for Vascular Surgery (SVS) Patient Safety Organization® and the Society for Vascular Medicine, in collaboration with the American Heart Association, for the Vascular Quality Initiative (VQI).
The VQI, a joint venture of M2S Inc. and the SVS, collects and analyzes data in order to help improve the quality of vascular care.
The Vascular Medicine Consult (VMC) registry will emphasize medication details and dosages, both risk factor and lifestyle modifications, nonoperative treatments and counseling those being treated medically for atherosclerotic carotid artery occlusive disease, abdominal aortic aneurysm and peripheral lower extremity arterial disease due to atherosclerosis or true aneurysm.
VMC’s value centers on the comparative effectiveness of surgery versus medically managing these vascular diseases.
“We are extremely excited about the introduction of the Vascular Medicine Consult registry,” said Jens Jorgensen, MD, VQI medical director.
“The effort and collaboration put into the VMC will provide a necessary platform for physicians to manage, analyze and improve outcomes for patients with peripheral arterial disease being treated with medical therapy. Data generated by the registry will directly support our goal of improving care for medically managed patients.”
